Using EUS-guided biliary drainage as a primary modality to drain distal malignant biliary obstruction

Primary EUS-guided biliary drainage Versus ERCP biliary drainage in distal malignant biliary obstruction

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

PACTR

Registry ID

PACTR202203635372753

Enrollment

Registered

2022-03-03

Start date

2021-12-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Digestive System

Interventions

ERCP group

EUS guidied biliary drainage

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: • Patients older than 18 years and diagnosed with malignant obstruction of the distal bile duct. • Type of malignancy: ? Primary pancreatic cancer. ? Ampulla of vater carcinoma. ? Distal cholangiocarcinoma. ? Pancreatic neuroendocrine tumor. ? Metastatic lymph nodes. ? Resectable and unresectable tumors will be included. ? Patients with duodenal tumor invasion will be included. • Patients with performance A will be included.

Exclusion criteria

Exclusion criteria: Exclusion criteria: • Patients with impaired coagulation profile. • Patients with sepsis (according to the severity of sepsis index). • Low performance. • Life expectancy less than 1 month.

Design outcomes

Primary

Measure	Time frame
Assessment of effectiveness and Safty of EUS guided biliary drainage as a primary tool.	—

Secondary

Measure	Time frame
Assessment improvement of sepsis	—

Countries

Egypt

Contacts

Public ContactMohamed Kandyl

Researcher of Gastroenterology and Hepatology Theodor Bilharz Reseach Institute

drmkandyl84@gmail.com+201114886247

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026